Orthostatic Hypotension

Lundbeck Neurogenic Orthostatic Hypotension protocol #16306A<- click for more information

Basic Eligibility Criteria:

  • 18 Years and older and able to stand
  • Clinical diagnosis of symptomatic orthostatic hypotension associated with Primary Autonomic Failure
  • Patients who are taking prescribed droxidopa therapy are eligible to participate in the study if they meet the other inclusion criteria and also have been on a stable dose of prescribed droxidopa for at least 2 weeks prior to the Screening Visit

 

-------------------

If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:

Irina Gamerman, M.D., Clinical Research Manager, at [email protected]

Clinical Research Coordinator:

 

Micah Sy at [email protected]

You may also call 203.333.1151 and we will be happy to answer any of your questions.